May Clearing Nasal Viruses Improve Allergic Rhinitis?

A phase 2 randomized trial suggests reducing nasal commensal viruses with ribavirin spray may improve allergic rhinitis symptoms while supporting a proposed disease mechanism.

By
Andrea Surnit
July 7, 2026
4 min

MDSpire News

Overview

A phase 2 randomized clinical trial suggests that ribavirin nasal spray may reduce symptoms in patients with allergic rhinitis by decreasing nasal commensal virus abundance. The study indicates improvements in Total Nasal Symptom Score and other secondary endpoints compared to placebo.

Background

Allergic rhinitis is a common condition that significantly impacts quality of life. Recent studies have indicated that nasal commensal viruses may play a role in the pathophysiology of allergic rhinitis through inflammatory pathways. Understanding the relationship between nasal viruses and allergic symptoms is important.

Data Highlights

Endpoint	Ribavirin Group	Placebo Group
Total Nasal Symptom Score	Lower after 4 weeks	Unchanged
Visual Analog Scale	Improved	Unchanged
Rhinitis Control Assessment Test	Improved	Unchanged
Adverse Events	No grade 3 or higher	N/A

Key Findings

Ribavirin nasal spray reduced Total Nasal Symptom Score after 4 weeks compared to placebo.
Improvements were also noted in Visual Analog Scale and Rhinitis Control Assessment Test scores.
Ribavirin treatment led to a decrease in nasal commensal virus abundance.
No serious adverse events were reported during the trial.
Exploratory analyses indicated that patients with higher baseline viral abundance experienced greater symptom improvement.
One-year follow-up suggested lower symptom scores in the ribavirin group compared to placebo.

Clinical Implications

Further research in larger, multicenter trials is necessary to validate these results and assess the long-term safety and efficacy of ribavirin nasal spray.

Conclusion

This study indicates that reducing nasal commensal viruses with ribavirin may improve allergic rhinitis symptoms. Larger trials are needed to confirm these findings.